发明名称 |
5-Ht1f mediated inhibition of neurogenic meningeal extra-vasation a method for the treatment of migraine |
摘要 |
The present invention provides a method for the treatment of migraine and associated disorders which relies on a novel mechanism of action. By treating a migraineur with compounds or compositions which are selective agonists of 5-HT1F receptors relative to other serotonin receptors which produce unwanted effects like vasoconstriction, the neurogenic meningeal extravasation which leads to the pain of migraine is inhibited and the physiological liabilities of compounds exhibiting vasoconstriction or other side effects are avoided. |
申请公布号 |
ZA9508314(B) |
申请公布日期 |
1997.04.03 |
申请号 |
ZA19950008314 |
申请日期 |
1995.10.03 |
申请人 |
ELI LILLY AND COMPANY |
发明人 |
JAMES EDMUND AUDIA;THERESA BRANCHEK;MARLENE LOIS COHEN;KIRK WILLIS JOHNSON;LEE ALAN PHEBUS |
分类号 |
A61K45/00;A61K31/00;A61K31/135;A61K31/40;A61K31/403;A61K31/4045;A61K31/445;A61K31/454;A61K31/4545;A61K31/48;A61P25/04;A61P25/06;A61P43/00 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|